By Martin Bowyer on
Clarity on the Updated Guidelines for ERA of Human Pharmaceuticals
News Type: General
Tags: Pharmaceuticals
European Medicines Agency provides Clarity on the Updated Guidelines for Environmental Risk Assessment of Human Pharmaceuticals Towards the end of...
By Martyn Shenton on
UK PFAS Policy: From Evidence Gathering to Potential Phase-Outs
News Type: General
Tags: PFAS
Following the publication of the UK PFAS Plan by DEFRA in February 2026, a UK Parliamentary Committee has issued recommendations calling for the ph...
By Damien Carson on
Blue Frog Scientific Joins Certania
News Type: General
Tags: General
A New Chapter… and a Bigger Platform for Greater Regulatory Science We’ve got some big news… Blue Frog Scientific has joined Certania – an intern...
By Kai Paul on
A Regulatory Framework for Assessing the Variability & Safety of Nanoforms
News Type: General
Tags: Nanomaterials
Rethinking Nanoform Regulation: Towards a More Proportionate, Science-Based Framework Nanomaterials are at the heart of modern innovation – but regu...
By Martin Bowyer on
Environmental Risk Assessment of Generic Human Pharmaceuticals
News Type: General
Tags: Pharmaceuticals
Environmental Risk Assessment for Generics: Necessary Safeguard or Costly Box-Ticking? Environmental Risk Assessment (ERA) has long been part of p...
